110 related articles for article (PubMed ID: 19605546)
1. Impaired transcription factor interplay in addition to advanced glycation end products suppress podocalyxin expression in high glucose-treated human podocytes.
Drossopoulou GI; Tsotakos NE; Tsilibary EC
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F594-603. PubMed ID: 19605546
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end products suppress neuropilin-1 expression in podocytes by a reduction in Sp1-dependent transcriptional activity.
Bondeva T; Wolf G
Am J Nephrol; 2009; 30(4):336-45. PubMed ID: 19590177
[TBL] [Abstract][Full Text] [Related]
3. Enhanced podocalyxin expression alters the structure of podocyte basal surface.
Economou CG; Kitsiou PV; Tzinia AK; Panagopoulou E; Marinos E; Kershaw DB; Kerjaschki D; Tsilibary EC
J Cell Sci; 2004 Jul; 117(Pt 15):3281-94. PubMed ID: 15226400
[TBL] [Abstract][Full Text] [Related]
4. PINCH1 is transcriptional regulator in podocytes that interacts with WT1 and represses podocalyxin expression.
Wang D; Li Y; Wu C; Liu Y
PLoS One; 2011 Feb; 6(2):e17048. PubMed ID: 21390327
[TBL] [Abstract][Full Text] [Related]
5. Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes.
Gu L; Hagiwara S; Fan Q; Tanimoto M; Kobata M; Yamashita M; Nishitani T; Gohda T; Ni Z; Qian J; Horikoshi S; Tomino Y
Nephrol Dial Transplant; 2006 Feb; 21(2):299-313. PubMed ID: 16263740
[TBL] [Abstract][Full Text] [Related]
6. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H
J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727
[TBL] [Abstract][Full Text] [Related]
7. Wilms' tumor protein Wt1 regulates the Interleukin-10 (IL-10) gene.
Sciesielski LK; Kirschner KM; Scholz H; Persson AB
FEBS Lett; 2010 Nov; 584(22):4665-71. PubMed ID: 20974136
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D receptor activators upregulate and rescue podocalyxin expression in high glucose-treated human podocytes.
Verouti SN; Tsilibary EC; Fragopoulou E; Iatrou C; Demopoulos CA; Charonis AS; Charonis SA; Drossopoulou GI
Nephron Exp Nephrol; 2012; 122(1-2):36-50. PubMed ID: 23548800
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II upregulates RAGE expression on podocytes: role of AT2 receptors.
Rüster C; Bondeva T; Franke S; Tanaka N; Yamamoto H; Wolf G
Am J Nephrol; 2009; 29(6):538-50. PubMed ID: 19129693
[TBL] [Abstract][Full Text] [Related]
10. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis.
Patek CE; Fleming S; Miles CG; Bellamy CO; Ladomery M; Spraggon L; Mullins J; Hastie ND; Hooper ML
Hum Mol Genet; 2003 Sep; 12(18):2379-94. PubMed ID: 12915483
[TBL] [Abstract][Full Text] [Related]
11. Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells.
Vidovic K; Svensson E; Nilsson B; Thuresson B; Olofsson T; Lennartsson A; Gullberg U
Leukemia; 2010 May; 24(5):992-1000. PubMed ID: 20237505
[TBL] [Abstract][Full Text] [Related]
12. [Connective tissue growth factor mediates high glucose-induced down-regulation of podocalyxin expression in mouse podocytes].
Zhang J; Li PH; Yang L; DU QS; Guo TT; Tang X
Nan Fang Yi Ke Da Xue Xue Bao; 2011 May; 31(5):839-43. PubMed ID: 21602138
[TBL] [Abstract][Full Text] [Related]
13. Regulated expression of the alpha isoform of the human thromboxane A2 receptor during megakaryocyte differentiation: a coordinated role for WT1, Egr1, and Sp1.
Gannon AM; Turner EC; Reid HM; Kinsella BT
J Mol Biol; 2009 Nov; 394(1):29-45. PubMed ID: 19747485
[TBL] [Abstract][Full Text] [Related]
14. Glucose-induced gradual phenotypic modulation of cultured human glomerular epithelial cells may be independent of Wilms' tumor 1 (WT1).
Tsotakos NE; Sagnou M; Kotsopoulou ES; Tsilibary EC; Drossopoulou GI
BMC Cell Biol; 2013 Jun; 14():28. PubMed ID: 23768159
[TBL] [Abstract][Full Text] [Related]
15. Effect of taurine-conjugated ursodeoxycholic acid on endoplasmic reticulum stress and apoptosis induced by advanced glycation end products in cultured mouse podocytes.
Chen Y; Liu CP; Xu KF; Mao XD; Lu YB; Fang L; Yang JW; Liu C
Am J Nephrol; 2008; 28(6):1014-22. PubMed ID: 18648192
[TBL] [Abstract][Full Text] [Related]
16. Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats.
Kim YS; Kim NH; Lee SW; Lee YM; Jang DS; Kim JS
Eur J Pharmacol; 2007 Aug; 569(3):171-9. PubMed ID: 17597607
[TBL] [Abstract][Full Text] [Related]
17. Expression of Wilms' tumor suppressor in the liver with cirrhosis: relation to hepatocyte nuclear factor 4 and hepatocellular function.
Berasain C; Herrero JI; García-Trevijano ER; Avila MA; Esteban JI; Mato JM; Prieto J
Hepatology; 2003 Jul; 38(1):148-57. PubMed ID: 12829997
[TBL] [Abstract][Full Text] [Related]
18. WT1 regulates the expression of the major glomerular podocyte membrane protein Podocalyxin.
Palmer RE; Kotsianti A; Cadman B; Boyd T; Gerald W; Haber DA
Curr Biol; 2001 Nov; 11(22):1805-9. PubMed ID: 11719225
[TBL] [Abstract][Full Text] [Related]
19. Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells.
Matsuoka T; Kajimoto Y; Watada H; Kaneto H; Kishimoto M; Umayahara Y; Fujitani Y; Kamada T; Kawamori R; Yamasaki Y
J Clin Invest; 1997 Jan; 99(1):144-50. PubMed ID: 9011569
[TBL] [Abstract][Full Text] [Related]
20. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
Han S; Inoue H; Flowers LC; Sidell N
Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]